Clinical Trial

TEAS for Variceal Bleeding Endoscopy in Cirrhosis

Study acronym: TEAS-VBE-C
Completed
View on ClinicalTrials.gov →
Summary
This randomized controlled trial evaluates whether transcutaneous electrical acupoint stimulation (TEAS) improves procedural success and patient tolerance in cirrhotic patients undergoing urgent unsedated endoscopy for suspected variceal bleeding. Participants with cirrhosis and suspected acute variceal bleeding requiring urgent endoscopy are randomly assigned to one of three groups: 1. Active TEAS: Electrical stimulation at bilateral Hegu (LI4), Neiguan (PC6), Zusanli (ST36), and Gongsun (SP4) starting 30 minutes before endoscopy and continuing until 15 minutes after the procedure. 2. Sham TEAS: Identical electrode placement but no electrical current. 3. Control: Standard endoscopy alone without electrodes. All patients receive topical pharyngeal anesthesia and standardized medical management. The study assesses procedural success (composite of technical adequacy and patient satisfaction), patient discomfort (visual analogue scale), procedure time, hemostasis outcomes, physiological parameters, and clinical experience measures.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-06-30 -> 2026-02-03 2026-04-14
minor Completion pushed: 2025-07-15 -> 2026-02-12 2026-04-14
Trial Details
NCT Number NCT07106658
Lead Sponsor Beijing 302 Hospital
Conditions Gastrointestinal Endoscopy, Upper Gastrointestinal Hemorrhage, Variceal Bleeding, Cirrhosis
Enrollment 180 participants
Start Date 2025-07-18
Primary Completion 2026-02-03 (estimated)
Study Completion 2026-02-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-13